Some Information for YOur Saturday and some things to be concerned about
and careful of.
God Bless
marty auslander
Monsanto's Hormonal Milk Poses Serious Risks of Breast Cancer, Besides
Other Cancers, Warns Professor of Environmental Medicine at the
University of Illinois School of Public Health
CHICAGO, June 21 /PRNewswire/ -- The following was released today by
Samuel S. Epstein, M.D., Professor Environmental Medicine, University of
Illinois School of Public Health and Chairman of Cancer Prevention
Coalition:
As reported in a May 9 article in The Lancet, women with a relatively
small
increase in blood levels of the naturally occurring growth hormone
Insulin-
like Growth Factor I (IGF-1) are up to seven times more likely to
develop
premenopausal breast cancer than women with lower levels. Based on
those
results, the report concluded that the risks of elevated IGF-1 blood
levels
are among the leading known risk factors for breast cancer, and are
exceeded
only by a strong family history or unusual mammographic abnormalities.
Apart
from breast cancer, an accompanying editorial warned that elevated IGF-1
levels are also associated with greater than any known risk factors for
other
major cancers, particularly colon and prostate.
This latest evidence is not unexpected. Higher rates of breast, besides
colon, cancer have been reported in patients with gigantism (acromegaly)
who
have high IGF-1 blood levels. Other studies have also shown that
administration of IGF-1 to elderly female primates causes marked breast
enlargement and proliferation of breast tissue, that IGF-1 is a potent
stimulator of human breast cells in tissue culture, that it blocks the
programmed self-destruction of breast cancer cells, and enhances their
growth
and invasiveness.
These various reports, however, appear surprisingly unaware of the fact
that
the entire U.S. population is now exposed to high levels of IGF-1 in
dairy
products. In February 1995, the Food and Drug Administration approved
the
sale of unlabelled milk from cows injected with Monsanto's genetically
engineered bovine growth hormone, rBGH, to increase milk production. As
detailed in a January 1996 report in the prestigious International
Journal of
Health Services, rBGH milk differs from natural milk chemically,
nutritionally, pharmacologically and immunologically, besides being
contaminated with pus and antibiotics resulting from mastitis induced by
the
biotech hormone. More critically, rBGH milk is supercharged with high
levels
of abnormally potent IGF-1, up 10 times the levels in natural milk and
over 10
times more potent. IGF-1 resists pasteurization, digestion by stomach
enzymes, and is well absorbed across the intestinal wall. Still
unpublished
1987 Monsanto tests, disclosed by FDA in summary form in 1990, revealed
that
statistically significant growth stimulating effects were induced in
organs of
adult rats by feeding IGF-1 at low dose levels for only two weeks.
Drinking
rBGH milk would thus be expected to significantly increase IGF-1 blood
levels
and consequently to increase risks of developing breast cancer and
promoting
its invasiveness.
Faced with escalating rates of breast, besides colon, prostate and other
avoidable cancers, FDA should withdraw its approval of rBGH milk, whose
sale
benefits only Monsanto while posing major public health risks for the
entire
U.S. population. A Congressional investigation of FDA's abdication of
responsibility is well overdue.
SOURCE Cancer Prevention Coalition
CO: Cancer Prevention Coalition
ST: Illinois
IN: HEA MTC
SU:
06/21/98 16:00 EDT http://www.prnewswire.com
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
